樹状細胞療法と多能性幹細胞

参考文献

1) Nakano T, Kodama H, Honjo T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 1994 265 :1098-1101.

2) Senju S, Hirata, S, Matsuyoshi H et al . Generation and genetic modifi cation of dendritic cells derived from mouse embryonic stem cells.Blood 2003. 101 : 3501-3508.

3) Matsuyoshi H, Senju S, Hirata S et al. Enhanced priming of antigenspecifi c CTL in vivo by transfer of ES cell-derived dendritic cells expressing chemokine along with antigenic protein；application to anti-tumorvaccination.J. Immunol. 2004172: 776-786.

4) Matsuyoshi H, Hirata S, Yoshitake Y et al. Therapeutic effect of α -galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells. Cancer Science 2005 96 :889-896.

5) Hirata S, Senju S, Matsuyoshi H et al. Prevention of experimental autoimmune encephalomyelitis by transfer of ES cell-derived dendritic cells expressing MOG peptide along with TRAIL or PD-L1. J. Immunol. 2005 174 : 1888-1897.

6) Hirata S, Matsuyoshi H, Fukuma D et al. Involvement of regulatory T cells in the experimental autoimmune encephalo-myelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL. J Immunol 2007 178 :918-925.

7) Senju S, Suemori H, Zembutsu et al. Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory function. Stem Cells 2007 25 : 2720-2729.

8) Senju S, Haruta M, Matsunaga Y, et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells. Stem Cells 2009 27 :1021-1031.

9) Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007 448 :313-317.

10) Fairchild PJ, Brook FA, Gardner RL, et al . Directed differentiation of dendritic cells from mouse embryonic stem cells. Curr Biol 2000;10 :1515- 1518.

11) Zhan X, Dravid G, Ye Z, et al . Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro . Lancet 2004;364 :163- 171.

12) Slukvin , Vodyanik MA, Thomson JA, et al . Directed differentiation of human embryonic stem cells into functional dendritic cells through the myeloid pathway. J Immunol 2006;176 :2924-2932.

13) Su Z, Frye C, Bae KM, et al . Differentiation of human embryonic stem cells into immunostimulatory dendritic cells under feeder-free culture conditions. Clin Cancer Res 2008;14 :6207-6217.

14) Choi KD, Vodyanik MA, Slukvin . Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43 +CD45+ progenitors J Clin Invest 119 2009 :2818-2829.

15) Nakatsuji N, Nakajima F, Tokunaga K. HLA-haplotype banking and iPS cells. Nature Biotechnol 2008 26 :739 - 740.

16) Matsunaga Y, Fukuma, D, Hirata S et al. Activation of antigen-specifi c CTL by beta 2-microglobulin or TAP1 gene-disrupted and recipient-matched MHC class gene-introduced allogeneic ES cell-derived dedritic cells. J.Immunol. 2008 181 :6635-6643.